Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    2seventy bio Inc.

    NASDAQ: TSVT · Real-Time Price · USD
    5.00
    0.00 (0.00%)
    At close: May 12, 2025, 3:59 PM

    2seventy bio Statistics

    Share Statistics

    2seventy bio has 52.34M shares outstanding. The number of shares has increased by 1.81% in one year.

    Shares Outstanding

    n/a
    		 52.34M

    Shares Change (YoY)

    n/a
    		 1.81%

    Shares Change (QoQ)

    n/a
    		 1.45%

    Owned by Institutions (%)

    n/a
    		 87.93%

    Shares Floating

    n/a
    		 42.7M

    Failed to Deliver (FTD) Shares

    n/a
    		 142

    FTD / Avg. Volume

    n/a
    		 0.01%

    Short Selling Information

    The latest short interest is 2.59M, so 4.87% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 2.59M

    Short % of Shares Out

    n/a
    		 4.87%

    Short % of Float

    n/a
    		 5.07%

    Short Ratio (days to cover)

    n/a
    		 4.4

    Valuation Ratios

    The PE ratio is -2.68 and the forward PE ratio is -33.33. 2seventy bio's PEG ratio is 0.04.

    PE Ratio

    n/a
    		 -2.68

    Forward PE

    n/a
    		 -33.33

    PS Ratio

    n/a
    		 4.05

    Forward PS

    n/a
    		 3

    PB Ratio

    n/a
    		 0.73

    P/FCF Ratio

    n/a
    		 -1.79

    PEG Ratio

    n/a
    		 0.04
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for 2seventy bio.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 4.67, with a Debt / Equity ratio of 1.16.

    Current Ratio

    n/a
    		 4.67

    Quick Ratio

    n/a
    		 4.67

    Debt / Equity

    n/a
    		 1.16

    Debt / EBITDA

    n/a
    		 -2.11

    Debt / FCF

    n/a
    		 -2.84

    Interest Coverage

    n/a
    		 0

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 $582,492.31

    Profits Per Employee

    n/a
    		 $-880,723.08

    Employee Count

    n/a
    		 65

    Asset Turnover

    n/a
    		 0.08

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 n/a

    Effective Tax Rate

    n/a
    		 0%

    Stock Price Statistics

    The stock price has increased by 9.89% in the last 52 weeks. The beta is 1.05, so 2seventy bio's price volatility has been higher than the market average.

    Beta

    n/a
    		 1.05

    52-Week Price Change

    n/a
    		 9.89%

    50-Day Moving Average

    n/a
    		 4.93

    200-Day Moving Average

    n/a
    		 4.07

    Relative Strength Index (RSI)

    n/a
    		 72.25

    Average Volume (20 Days)

    n/a
    		 1,373,116

    Income Statement

    In the last 12 months, 2seventy bio had revenue of 37.86M and earned -57.25M in profits. Earnings per share was -1.1.

    Revenue

    n/a
    		 37.86M

    Gross Profit

    n/a
    		 15.3M

    Operating Income

    n/a
    		 -115.43M

    Net Income

    n/a
    		 -57.25M

    EBITDA

    n/a
    		 -115.43M

    EBIT

    n/a
    		 -105.54M

    Earnings Per Share (EPS)

    n/a
    		 -1.1
    Full Income Statement

    Balance Sheet

    The company has 71.24M in cash and 243.72M in debt, giving a net cash position of -172.47M.

    Cash & Cash Equivalents

    n/a
    		 71.24M

    Total Debt

    n/a
    		 243.72M

    Net Cash

    n/a
    		 -172.47M

    Retained Earnings

    n/a
    		 -568.46M

    Total Assets

    n/a
    		 480M

    Working Capital

    n/a
    		 157.19M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -85M and capital expenditures -707K, giving a free cash flow of -85.7M.

    Operating Cash Flow

    n/a
    		 -85M

    Capital Expenditures

    n/a
    		 -707K

    Free Cash Flow

    n/a
    		 -85.7M

    FCF Per Share

    n/a
    		 -1.64
    Full Cash Flow Statement

    Margins

    Gross margin is 40.41%, with operating and profit margins of -304.87% and -151.2%.

    Gross Margin

    n/a
    		 40.41%

    Operating Margin

    n/a
    		 -304.87%

    Pretax Margin

    n/a
    		 -151.2%

    Profit Margin

    n/a
    		 -151.2%

    EBITDA Margin

    n/a
    		 -304.87%

    EBIT Margin

    n/a
    		 -304.87%

    FCF Margin

    n/a
    		 -226.36%

    Dividends & Yields

    TSVT does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    Currently there are no analyst rating for TSVT.

    Price Target

    n/a
    		 $5

    Price Target Difference

    n/a
    		 0%

    Analyst Consensus

    n/a
    		 Hold

    Analyst Count

    n/a
    		 3
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Scores

    Altman Z-Score

    n/a
    		 -0.97

    Piotroski F-Score

    n/a
    		 1

    Add to Watchlist